Is it possible to overstate the potential of a new technology that efficiently and cheaply permits deliberate, specific, and multiple genomic modifications to almost anything biological? What if that technology was also capable of altering untold future generations of nearly any given species—including the one responsible for creating it? And what if it could be used, for better or worse, to rapidly exterminate an entire species?
Certain experts have no intention of veiling their enthusiasm—or their unease. Consider, for example, biologist David Baltimore, who recently chaired an international summit dedicated primarily to the technology’s much-disputed ethical implications. “The unthinkable has become conceivable,” he warned his audience in early December. Powerful new gene-editing techniques, he added, have placed us “on the cusp of a new era in human history.”
If so, it might seem somewhat anticlimactic to note that Science magazine dubbed this technology its “Breakthrough of the Year” for 2015, or that its primary developers are widely considered shoo-ins for a Nobel Prize— in addition, that is, to the $3 million Breakthrough Prize in Life Sciences already earned by two such researchers. All of which might sound trifling compared to the billions up for grabs following imminent resolution of a now-vicious patent dispute.
Leggete l'articolo completo e molti altri in questo numero di
Skeptical Inquirer
Opzioni di acquisto di seguito
Se il problema è vostro,
Accesso per leggere subito l'articolo completo.
Singolo numero digitale
May June 2016
 
Questo numero e altri numeri arretrati non sono inclusi in un nuovo
abbonamento. Gli abbonamenti comprendono l'ultimo numero regolare e i nuovi numeri pubblicati durante l'abbonamento. Skeptical Inquirer
Abbonamento digitale annuale
€19,99
fatturati annualmente